All stock reports

BBL evidence report

Evidence date: 2026-10-01. Research observations only.

What can I do with this stock?

Evaluated 2026-10-02T01:37:53.224812+00:00. Closed-session evidence: 2026-10-01. This is a timestamped assessment, not a live trading feed.

Strategy evidence, instrument feasibility and portfolio suitability are separate. Portfolio suitability has not been assessed.

Today: intraday

Evidence unavailable

No current intraday signal and observed quote supplied; daily bars cannot establish a live setup.

  • No current intraday signal and observed quote supplied; daily bars cannot establish a live setup.

Next week: five trading sessions

No qualifying opportunity

No candidate with a primary five-session horizon in the coherent source run.

  • No candidate with a primary five-session horizon in the coherent source run.

Long term: one to three years

Research only

A financial screen alone does not establish an investment recommendation.

  • Financial data quality flags require resolution.
  • A current, source-backed thesis and valuation review is required.

Investment evidence

Statement coverage
FULL_STATEMENTS
Financial source retrieved
2026-08-31T14:00:55.012995+00:00

Metrics

latest_annual_period
2026-03-31
revenue
22738000000.0
net_income
1200900000.0
operating_cash_flow
-666600000.0
free_cash_flow
-1801200000.0
total_assets
31118200000.0
total_liabilities
10830900000.0
total_equity
20287300000.0
cash
2690400000.0
total_debt
3066700000.0
revenue_growth
0.19567332215029798
earnings_growth
-0.10145903479236817
net_margin
0.05281467147506377
roe
0.05919466858576548
debt_to_equity
0.1511635358081164
cash_conversion
-0.555083687234574
free_cash_flow_margin
-0.07921541032632598
trailing_pe
23.2273
forward_pe
6.1387
peg_ratio
Not supplied
price_to_book
1.2978
dividend_yield
0.0

Other positional research

Research only

2 opportunity assessments; compare evidence and conditions below.

Mean Reversion Capitulation

Research only. Direction: LONG.

Tests recovery after an extreme price/volume dislocation

  • No active, unexpired validation authority for this exact strategy and horizon.
  • A source-backed entry, invalidation, exit and cost plan is not supplied.
Eligible expression
None selected
Expression comparison
No eligible instrument selected.
Invalidation
Continued trend momentum breakdown
Entry rule
Not supplied
Entry range (INR)
Not supplied
Exit / review rule
Not supplied
Planned exit
Not supplied
Plan valid until
Not supplied
Promotion reference
Not supplied
Instrument scenarios in INR; quantities are illustrative, not personal sizing
InstrumentEvidence statusContractQuantityCapital / marginTarget P&L after costsStop-level scenario P&LStress lossConditions and limitations
NO_POSITIONAvailableNot suppliedNot suppliedNot supplied0.000.00Not suppliedNo new position; incremental trading P&L is zero.
CASHUnavailableNot suppliedNot suppliedNot suppliedNot suppliedNot suppliedNot suppliedObserved contract, quote and cost evidence not supplied.
FUTURESUnavailableNot suppliedNot suppliedNot suppliedNot suppliedNot suppliedNot suppliedObserved contract, quote and cost evidence not supplied.
OPTIONSUnavailableNot suppliedNot suppliedNot suppliedNot suppliedNot suppliedNot suppliedObserved contract, quote and cost evidence not supplied.
  • No reader capital or loss budget supplied

Price Dislocation

Research only. Direction: LONG.

Flags large price dislocations for research without asserting unsupported fundamental quality

  • No active, unexpired validation authority for this exact strategy and horizon.
  • A source-backed entry, invalidation, exit and cost plan is not supplied.
Eligible expression
None selected
Expression comparison
No eligible instrument selected.
Invalidation
Continued price deterioration or adverse fundamental evidence
Entry rule
Not supplied
Entry range (INR)
Not supplied
Exit / review rule
Not supplied
Planned exit
Not supplied
Plan valid until
Not supplied
Promotion reference
Not supplied
Instrument scenarios in INR; quantities are illustrative, not personal sizing
InstrumentEvidence statusContractQuantityCapital / marginTarget P&L after costsStop-level scenario P&LStress lossConditions and limitations
NO_POSITIONAvailableNot suppliedNot suppliedNot supplied0.000.00Not suppliedNo new position; incremental trading P&L is zero.
CASHUnavailableNot suppliedNot suppliedNot suppliedNot suppliedNot suppliedNot suppliedObserved contract, quote and cost evidence not supplied.
FUTURESUnavailableNot suppliedNot suppliedNot suppliedNot suppliedNot suppliedNot suppliedObserved contract, quote and cost evidence not supplied.
OPTIONSUnavailableNot suppliedNot suppliedNot suppliedNot suppliedNot suppliedNot suppliedObserved contract, quote and cost evidence not supplied.
  • No reader capital or loss budget supplied
Decision provenance and limitations
Decision ID
decision-5a4bd0bda0b5dd23998452aa4a555f708c3d66b537890cbe7946f16fdd0acff7
Policy
stock-decisions-v1
Evidence bundle hash
7c93b6302d5ac3d713324ceb563c72b492ff11924651ab48c56057b36459af39
  • market-brief: a7de4d64fedac164d48cdfb9b4081a4666d7f797f7d9c58da304b329b3a61d3c
  • validation-registry: b1069587129bfc64a703cdf8322d0294692585b7d67f5472593e4164bbb0c3bc
  • financial-statements: 052fb598b5c5146f434e2acb1cb9592bea0ffbe98aedaa60aff5c9be327ef7b7
  • daily-price: ec220d7b06f7b25ef8a681af00abab7e80d153ca912e4e5333e4d64ed2b5b441
  • Conditional research decisions are not orders or personalized position sizes.
  • Scenario payoffs are assumptions, not probabilities or expected returns.
  • A stop price does not guarantee a maximum loss through a gap or illiquidity.

Download the decision evidence as JSON

Evidence briefing

The local language model selected and grouped the following supplied facts.

Overview

The cached financial metric latest annual period is 2026-03-31. The cached financial metric revenue growth is 0.19567332215029798. The cached financial metric net margin is 0.05281467147506377. The cached financial metric roe is 0.05919466858576548. The cached financial metric debt to equity is 0.1511635358081164. Price source verification: REPAIRED.

Risks

The trailing 5-session price return was -6.06%. The trailing 20-session price return was -9.55%. The trailing 60-session price return was -20.62%. The trailing 250-session price return was -33.75%. The closing price was -36.82% below its highest close in the available trailing year. Financial data check: weak_cash_conversion: operating cash flow/net income below 0.5.

Follow Up

Average cached traded value over twenty sessions was INR 41,983,581. The cached financial metric cash conversion is -0.555083687234574. The cached financial metric free cash flow margin is -0.07921541032632598. Historical observations do not establish future returns. No verified current news or catalyst evidence is supplied.

Cached observations and evidence limits